SAGE Therapeutics Company
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Technology:
AgeTech Companies
Industry:
Digital Pharmacy, mHealth UK 2022
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2010
Employees Number:
501-1000
Funding Status:
IPO
Investors Number:
6
Total Funding:
2701000000
Estimated Revenue:
$50M to $100M
Last Funding Date:
27 11 20
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership